Elevation Point Wealth Partners, LLC Boosts Johnson & Johnson Stake in Latest 13F Filing
Elevation Point Wealth Partners, LLC Boosts Johnson & Johnson Stake in Latest 13F Filing
Elevation Point Wealth Partners, LLC has made a significant move in its portfolio, as revealed in its latest SEC 13F filing. The firm increased its holdings in Johnson & Johnson (NYSE: JNJ) by adding an impressive 18,260 shares to its position. This adjustment underscores the investment firm's confidence in the medical biology giant.
Deep Dive into the Trade
The recent addition brings Elevation Point Wealth Partners, LLC's stake in Johnson & Johnson to a market value of approximately $12.46 million, representing 1.22% of the firm's overall portfolio. Despite the notable share increase, the percentage change in the position size remained steady at 0.0%, suggesting this move aligns with the firm's broader portfolio strategy.
Johnson & Johnson operates in the Medical Biology sector, a field known for its resilience and growth potential, especially in the context of global healthcare advancements. This sector's stability may have influenced the firm's decision to bolster its position in the company.
Market Context: Why Elevation Point Wealth Partners Invested in JNJ
Investors might wonder, "Why is Elevation Point Wealth Partners adjusting its position in Johnson & Johnson?" The answer could lie in JNJ's strong fundamentals and its diversified portfolio of healthcare products, which positions it as a leader in the industry. Additionally, Johnson & Johnson's consistent dividend payments and robust financial health make it a staple in many institutional portfolios.
Another critical question is, "How much of Johnson & Johnson does Elevation Point Wealth Partners own?" According to the filing, the firm's ownership percentage in the company is negligible, at 0.0% of total shares outstanding. This indicates that while the position is meaningful within the firm's portfolio, it represents a small fraction of Johnson & Johnson's overall market capitalization.
Portfolio Impact
With this move, Johnson & Johnson now comprises 1.22% of Elevation Point Wealth Partners, LLC's total portfolio. This adjustment highlights the firm's strategy of maintaining a balanced yet focused allocation towards high-quality healthcare stocks.
For a closer look at Elevation Point Wealth Partners, LLC’s complete portfolio and historical 13F filings, view Elevation Point Wealth Partners, LLC’s full real-time portfolio and historical 13F data here.